Tatva Chintan IPO allotment date, latest GMP and more details

Tatva Chintan IPO allotment date, latest GMP and more details

Tatva Chintan IPO: After record subscription of over 180 times of the original offer, Tatva Chintan Pharma IPO (Initial Public Offer) became the second most subscribed IPO in 2021 after MTAR Technologies. Now, bidders are eagerly waiting for the share allotment date as market observers are expecting huge listing gain from the initial offer. As Tatva Chintal IPO allotment date is fast approaching, Tatva Chintan IPO GMP (grey market premium) has become highly bullish now. Tatva Chintan shares are available at ₹1005 to ₹1010 premium in the grey market today. So, there is rise of ₹1005 to ₹1010 in the grey market premium of the public issue today.

Here we list out more details of Tatva Chintan IPO:

Tatva Chintan IPO GMP today

As per the market observers, Tatva Chintan IPO GMP today is ₹1005 to ₹1010 that means the market is expecting ₹1005 to ₹1010 listing gain on each shares of Tatva Chintan Pharma. That means the expected Tatva Chintan IPO listing price is around ₹2088 to ₹2093.

Tatva Chintan IPO allotment date

As per the Red Herring Prospectus (RHP), Tatva Chintan share allocation will be finalised on 26th July 2021.

Tatva Chintan IPO listing date

The public issue is expected to get listed at both NSE and BSE on 29th July 2021.

Tatva Chintan IPO allotment status check

Those who have applied for Tatva Chintan IPO, can check the share allotment status online by logging in at the direct BSE website link — bseindia.com/investors/appli_check.aspx or at the official registrar Link Intime India Private Ltd official website — ris.Linkintime.com/ipostatus/.

This public issue type is 100 per cent Book Building and after listing promoters' share in the company will come down from existing 100 per cent to 79.17 per cent.

Subscribe to Mint Newsletters * Enter a valid email * Thank you for subscribing to our newsletter.

Tatva Chintan Pharma Chem IPO: Know about ALLOTMENT date and how to check status online via BSE, Link Intime – Know here

If you have invested in the Initial Public Offering (IPO) of speciality chemicals manufacturing company Tatva Chintan Pharma Chem Ltd then you must know the schedule from allotment to listing day. Here is the complete information about this public issue.

The issue ended on Tuesday (20 July) at 5 pm. The public issue was subscribed 107.33 times. The Retail Individual Investors (RIIs) have subscribed this issue 17.06 times. Meanwhile, the non-institutional investors subscribed the Tatva Chintan IPO shares 374.95 times. Qualified Institutional Buyers (QIBs) have subscribed this issue 64.59 times.

See Zee Business Live TV Streaming Below:

The Price Range of the equity shares is Rs 1073 to Rs 1083.

See the price wise break-up of bids HERE: (PIC)

Tatva Chintan Pharma Chem Ltd – Important Dates

Issues Closed on Tuesday (20 July) at 5 pm Finalisation of basis of allotment likely on 27 July as per Edelweiss while Zerodha puts the date on 26 July. Initiation of refunds likely on 28 July as per Edelweiss while Zerodha puts it on 27 July Transfer of IPO shares to demat accounts likely on 29 July as per Edelweiss while Zerodha puts it on 28 July IPO Listing date is 30 July as per Edelweiss while Zerodha puts it on 29 July

Investors must keep an eye on the two schedules mentioned above.

Tatva Chintan Pharma Chem Ltd IPO - Know how to check allotment

Step 1: Visit the link: bseindia.com/investors/appli_check.aspx on BSE official website.

Step 2: In the dropdown menu select ‘Equity’ for issue type

Step 3: Now, select the name of the IPO, which is Tatva Chintan Pharma Chem Ltd' in this case

Step 4: Here, you will be asked to verify application number & PAN number

Step 5: Hit search button and you are good to go. You can see your IPO allotment on the screen

Steps to check Tatva Chintan Pharma Chem Ltd Allotment on Link Intime:

Step 1: Visit Link Intime India Private Limited IPO allotment link: ris.Linkintime.com/ipostatus/

Step 2: Again, select IPO Name- Tatva Chintan Pharma Chem Ltd '

Step 3: Here, fill in details such as PAN number, application number or DP ID

Step 4: Now, click on ‘Search’ Button. You can now see your IPO Allotment on the screen.

This public issue comprised of equity shares aggregating up to Rs 500 cr out of which there is a fresh Issue of up to Rs 225 cr and an Offer for Sale (OFS) of up to Rs 275 crore. The issue type is 100 per cent Book Building.

Tatva Chintan IPO subscribed 35 times in Retail category: Check Allotment, GMP, Listing Date

Follow us on Image Source : TATVACHINTAN.COM Tatva Chintan IPO subscribed 35 times in Retail category: Check Allotment, GMP, Listing Date

Tatva Chintan Pharma Chem IPO has received a massive investor response, getting subscribed a whopping 180.36 times. The IPO received bids for 58,83,08,396 shares against 32,61,882 shares on offer, as per data available with the NSE.

The portion meant for qualified institutional buyers (QIBs) was subscribed 185.23 times, those reserved for non-institutional investors a whopping 512.22 times and retail individual investors (RIIs) quota received 35.35 times subscription.

Tatva Chintan Pharma Chem is a specialty chemical manufacturing company. Its IPO aggregating up to Rs 500 crore comprised a fresh issue of up to Rs 225 crore and an offer for sale of up to Rs 275 crore. Its price range was at Rs 1,073-1,083 per share. The company garnered Rs 150 crore from anchor investors. The IPO was fully subscribed within hours of opening on Friday.

Tatva Chintan IPO GMP

In the grey market, Tatva Chintan IPO is commanding a strong premium. The unlisted shares of Tatva Chintan are trading at a premium of Rs 700-730 over the issue price apiece.

Tatva Chintan IPO allotment status will be out by Monday evening. Investors can check their allotment status on … The refund will be initiated on Tuesday and shares will be credited into demat account on Tuesday and Wednesday. The shares of Tatva Chintan will be listed on the BSE and NSE on Tuesday (July 29).

The Vadodara-based firm exports most of its products to over 25 countries, including the US, China, Germany, Japan, South Africa, and the UK.

The company said that proceeds from the fresh issue will be used towards funding capital expenditure requirements for expansion of the company’s Dahej manufacturing facility; up-gradation of a research and development facility in Vadodara, and general corporate purposes.

READ MORE: What is Neobank? All you need to know

READ MORE: Glenmark Life Sciences IPO to open for subscription on July 27. Check details

Latest Business News